Gastrointestinal Conditions News

The FDA has issued orphan drug designation to AbbVie’s investigational interleukin-23 inhibitor risankizumab for children with Crohn’s disease, the company announced.

Exposure-based cognitive behavior therapy delivered via the internet improved gastrointestinal symptoms and quality of life in adolescents with irritable bowel syndrome, according to randomized controlled trial results.

The FDA granted PhaseRx Inc. orphan drug designation for PRX-OTC for the treatment of the rare liver disease ornithine transcarbamylase deficiency in children, according to the company.

BOSTON — Primary sclerosing cholangitis affects children quickly and harshly, with 30% of patients requiring a liver transplant by 10 years after diagnosis, according to a presenter at The Liver Meeting 2016.

Gilead Sciences Inc. announced that the EMA’s scientific committee — Committee for Medicinal Products for Human Use — has adopted a positive opinion on its Marketing Authorization Application for Vemlidy for the treatment of chronic hepatitis B virus infection in adults and adolescents aged 12 years and older.

Infant colonization with potentially pathogenic organisms and related antibiotic resistance occurred early during the first year of life, according to recent study findings.

About one in five children with celiac disease who adhere to a gluten-free diet have persistent enteropathy, researchers found.

Children and adolescents diagnosed with inflammatory bowel disease are just as likely to gain employment and get married in adulthood as their peers without IBD, and are even more likely to earn higher annual incomes and get a college education, according to a new study published in Clinical Gastroenterology and Hepatology.

NEW ORLEANS — John J. Treanor, MD, chief of infectious diseases at the University of Rochester Medical Center, reviews several vaccine candidates for norovirus that are currently being evaluated in clinical trials.

Young people with chronic liver disease and who may have undergone liver transplant experience high levels of depression and anxiety, per published findings in Liver Transplantation.